CDXC
Price:
$7.87
Market Cap:
$508.76M
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingred...[Read more]
Industry
Biotechnology
IPO Date
2008-06-25
Stock Exchange
NASDAQ
Ticker
CDXC
According to ChromaDex Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 71.55. This represents a change of 72.95% compared to the average of 41.37 of the last 4 quarters.
The mean historical PE Ratio of ChromaDex Corporation over the last ten years is -12.61. The current 71.55 PE Ratio has changed -56838.35% with respect to the historical average. Over the past ten years (40 quarters), CDXC's PE Ratio was at its highest in in the December 2023 quarter at 228.57. The PE Ratio was at its lowest in in the September 2015 quarter at -8023.52.
Average
-12.61
Median
-11.99
Minimum
-47.39
Maximum
53.05
Discovering the peaks and valleys of ChromaDex Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.84%
Maximum Annual PE Ratio = 53.05
Minimum Annual Increase = -359.69%
Minimum Annual PE Ratio = -47.39
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 53.05 | -359.69% |
| 2023 | -20.43 | 191.84% |
| 2022 | -7.00 | -24.43% |
| 2021 | -9.26 | -37.04% |
| 2020 | -14.71 | 92.31% |
| 2019 | -7.65 | 35.08% |
| 2018 | -5.66 | -77.25% |
| 2017 | -24.89 | -40.96% |
| 2016 | -42.16 | -11.04% |
| 2015 | -47.39 | 172.54% |
The current PE Ratio of ChromaDex Corporation (CDXC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.54
5-year avg
0.33
10-year avg
-12.61
ChromaDex Corporation’s PE Ratio is greater than Exscientia plc (-5.19), greater than Regulus Therapeutics Inc. (-11.36), greater than Sage Therapeutics, Inc. (-1.80), greater than Invivyd, Inc. (-6.30), greater than Ikena Oncology, Inc. (-26.94), greater than ARS Pharmaceuticals, Inc. (-13.10), greater than Sinovac Biotech Ltd. (-6.45), greater than Icosavax, Inc. (-6.88), greater than BioDelivery Sciences International, Inc. (6.80), greater than iTeos Therapeutics, Inc. (-2.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.19 | $633.18M | |
| -11.36 | $564.95M | |
| -1.80 | $544.94M | |
| -6.30 | $294.00M | |
| -26.94 | $718.82M | |
| -13.10 | $1.04B | |
| -6.45 | $464.94M | |
| -6.88 | $769.04M | |
| 6.80 | $577.05M | |
| -2.18 | $448.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChromaDex Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ChromaDex Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ChromaDex Corporation's PE Ratio?
How is the PE Ratio calculated for ChromaDex Corporation (CDXC)?
What is the highest PE Ratio for ChromaDex Corporation (CDXC)?
What is the 3-year average PE Ratio for ChromaDex Corporation (CDXC)?
What is the 5-year average PE Ratio for ChromaDex Corporation (CDXC)?
How does the current PE Ratio for ChromaDex Corporation (CDXC) compare to its historical average?